Identifying markers of immune response in ovarian cancer: does PD-L1 expression meet the mark?

Gaillard, S L; Coleman, R L

Gaillard, S L; Coleman, R L.

Afiliação

Gaillard SL; Departments of Oncology, Johns Hopkins School of Medicine, Baltimore; Gynecology and Obstetrics/Division of Gynecologic Oncology, Johns Hopkins School of Medicine, Baltimore. Electronic address: stephanie.gaillard@jhmi.edu.
Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, USA.

Ann Oncol ; 30(7): 1025-1028, 2019 07 01.

Article em En | MEDLINE | ID: mdl-31111866

Assuntos

Antígeno B7-H1; Neoplasias Ovarianas; Anticorpos Monoclonais Humanizados; Feminino; Humanos; Recidiva Local de Neoplasia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antígeno B7-H1 Limite: Female / Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google